低收入和中等收入国家在烟草控制政策方面处于领先地位

IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES BMJ Innovations Pub Date : 2022-01-01 DOI:10.1136/bmjinnov-2021-000857
Joanna E. Cohen, Graziele Grilo, Lauren Czaplicki, Jennifer L Brown, K. Welding, M. Hefler, R. Kennedy, A. Perucic
{"title":"低收入和中等收入国家在烟草控制政策方面处于领先地位","authors":"Joanna E. Cohen, Graziele Grilo, Lauren Czaplicki, Jennifer L Brown, K. Welding, M. Hefler, R. Kennedy, A. Perucic","doi":"10.1136/bmjinnov-2021-000857","DOIUrl":null,"url":null,"abstract":"© Author(s) (or their employer(s)) 2022. Reuse permitted under CC BYNC. No commercial reuse. See rights and permissions. Published by BMJ. GLOBAL TOBACCO USE AND POLICY INTERVENTIONS Tobacco products are the world’s single largest cause of preventable death, accounting for more than 8 million deaths each year and causing suffering from avoidable illnesses among tens of millions more. Tobaccocaused death and disease disproportionately affects people in lowincome and middleincome countries (LMICs). 2 The WHO Framework Convention on Tobacco Control (FCTC), with 182 parties from all regions of the world, was developed in response to the globalisation of the tobacco epidemic and lays out evidencebased demand and supply reduction strategies. These strategies have resulted in measurable progress: global cigarette sales have been declining since 2012 despite overall population growth. It is estimated that tobacco control interventions have saved more than 37 million lives as fewer people start and more people quit, using tobacco products. However, there is much more work needed ahead. Over 1 billion people worldwide still use tobacco products, and the tobacco industry continues to aggressively fight the enactment and effective implementation of proven policy interventions. The demand and supply measures outlined in the FCTC, adopted by the World Health Assembly in 2003, are considered a floor (after all, the Framework Convention was based on the best evidence available through the dawn of the 21st century). However, FCTC Article 2.1 explicitly encourages countries to go beyond the measures outlined, and they have! Early tobacco control policy innovations, with data of their impacts feeding into the development of the FCTC, included smokefree air policies in states and cities in the USA, pictorial health warning labels (HWLs) in Canada, restrictions on tobacco advertising and sponsorship in Canada, and the use of tobacco excise taxes as a measure to reduce smoking in Canada. Since the FCTC came into force, innovations have included a ban on the display of tobacco products at the point of sale in Iceland, and plain and standardised packaging in Australia. However, policy innovations have also occurred across LMICs. This commentary highlights seven diverse examples from across the globe, selected by the authors, of world precedent setting, firstoftheir kind interventions that have originated in LMICs.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"1 1","pages":"4 - 8"},"PeriodicalIF":1.4000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":"{\"title\":\"Low-income and middle-income countries leading the way with tobacco control policies\",\"authors\":\"Joanna E. Cohen, Graziele Grilo, Lauren Czaplicki, Jennifer L Brown, K. Welding, M. Hefler, R. Kennedy, A. Perucic\",\"doi\":\"10.1136/bmjinnov-2021-000857\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"© Author(s) (or their employer(s)) 2022. Reuse permitted under CC BYNC. No commercial reuse. See rights and permissions. Published by BMJ. GLOBAL TOBACCO USE AND POLICY INTERVENTIONS Tobacco products are the world’s single largest cause of preventable death, accounting for more than 8 million deaths each year and causing suffering from avoidable illnesses among tens of millions more. Tobaccocaused death and disease disproportionately affects people in lowincome and middleincome countries (LMICs). 2 The WHO Framework Convention on Tobacco Control (FCTC), with 182 parties from all regions of the world, was developed in response to the globalisation of the tobacco epidemic and lays out evidencebased demand and supply reduction strategies. These strategies have resulted in measurable progress: global cigarette sales have been declining since 2012 despite overall population growth. It is estimated that tobacco control interventions have saved more than 37 million lives as fewer people start and more people quit, using tobacco products. However, there is much more work needed ahead. Over 1 billion people worldwide still use tobacco products, and the tobacco industry continues to aggressively fight the enactment and effective implementation of proven policy interventions. The demand and supply measures outlined in the FCTC, adopted by the World Health Assembly in 2003, are considered a floor (after all, the Framework Convention was based on the best evidence available through the dawn of the 21st century). However, FCTC Article 2.1 explicitly encourages countries to go beyond the measures outlined, and they have! Early tobacco control policy innovations, with data of their impacts feeding into the development of the FCTC, included smokefree air policies in states and cities in the USA, pictorial health warning labels (HWLs) in Canada, restrictions on tobacco advertising and sponsorship in Canada, and the use of tobacco excise taxes as a measure to reduce smoking in Canada. Since the FCTC came into force, innovations have included a ban on the display of tobacco products at the point of sale in Iceland, and plain and standardised packaging in Australia. However, policy innovations have also occurred across LMICs. This commentary highlights seven diverse examples from across the globe, selected by the authors, of world precedent setting, firstoftheir kind interventions that have originated in LMICs.\",\"PeriodicalId\":53454,\"journal\":{\"name\":\"BMJ Innovations\",\"volume\":\"1 1\",\"pages\":\"4 - 8\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"11\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ Innovations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmjinnov-2021-000857\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Innovations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjinnov-2021-000857","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 11

摘要

©作者(或其雇主)2022。在CC BYNC下允许重用。禁止商业重用。请参阅权利和权限。英国医学杂志出版。烟草制品是世界上可预防死亡的最大单一原因,每年造成800多万人死亡,并使数千万人患上可避免的疾病。烟草造成的死亡和疾病对低收入和中等收入国家人民的影响尤为严重。2 .世卫组织《烟草控制框架公约》是为应对烟草流行全球化而制定的,有来自世界所有区域的182个缔约方,并规定了基于证据的减少需求和供应战略。这些战略取得了可衡量的进展:尽管总体人口增长,但自2012年以来,全球卷烟销量一直在下降。据估计,烟草控制干预措施挽救了3700多万人的生命,因为开始使用烟草制品的人减少了,戒烟的人增加了。然而,前面还有很多工作要做。全世界仍有超过10亿人使用烟草制品,烟草业继续积极反对制定和有效实施已证实的政策干预措施。2003年世界卫生大会通过的《烟草控制框架公约》概述的需求和供应措施被认为是一个底线(毕竟,《框架公约》是基于21世纪初可获得的最佳证据)。然而,《烟草控制框架公约》第2.1条明确鼓励各国超越概述的措施,而且它们已经这样做了!早期的烟草控制政策创新,其影响的数据为《烟草控制框架公约》的制定提供了依据,包括美国各州和城市的无烟空气政策,加拿大的健康警告图片标签,加拿大对烟草广告和赞助的限制,以及在加拿大使用烟草消费税作为减少吸烟的措施。自《烟草控制框架公约》生效以来,创新包括在冰岛禁止在销售点展示烟草制品,在澳大利亚禁止使用普通和标准化包装。然而,中低收入国家也出现了政策创新。本评论重点介绍了作者从全球各地挑选的七个不同的例子,这些例子是世界先例,是起源于中低收入国家的同类干预措施中的第一个。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Low-income and middle-income countries leading the way with tobacco control policies
© Author(s) (or their employer(s)) 2022. Reuse permitted under CC BYNC. No commercial reuse. See rights and permissions. Published by BMJ. GLOBAL TOBACCO USE AND POLICY INTERVENTIONS Tobacco products are the world’s single largest cause of preventable death, accounting for more than 8 million deaths each year and causing suffering from avoidable illnesses among tens of millions more. Tobaccocaused death and disease disproportionately affects people in lowincome and middleincome countries (LMICs). 2 The WHO Framework Convention on Tobacco Control (FCTC), with 182 parties from all regions of the world, was developed in response to the globalisation of the tobacco epidemic and lays out evidencebased demand and supply reduction strategies. These strategies have resulted in measurable progress: global cigarette sales have been declining since 2012 despite overall population growth. It is estimated that tobacco control interventions have saved more than 37 million lives as fewer people start and more people quit, using tobacco products. However, there is much more work needed ahead. Over 1 billion people worldwide still use tobacco products, and the tobacco industry continues to aggressively fight the enactment and effective implementation of proven policy interventions. The demand and supply measures outlined in the FCTC, adopted by the World Health Assembly in 2003, are considered a floor (after all, the Framework Convention was based on the best evidence available through the dawn of the 21st century). However, FCTC Article 2.1 explicitly encourages countries to go beyond the measures outlined, and they have! Early tobacco control policy innovations, with data of their impacts feeding into the development of the FCTC, included smokefree air policies in states and cities in the USA, pictorial health warning labels (HWLs) in Canada, restrictions on tobacco advertising and sponsorship in Canada, and the use of tobacco excise taxes as a measure to reduce smoking in Canada. Since the FCTC came into force, innovations have included a ban on the display of tobacco products at the point of sale in Iceland, and plain and standardised packaging in Australia. However, policy innovations have also occurred across LMICs. This commentary highlights seven diverse examples from across the globe, selected by the authors, of world precedent setting, firstoftheir kind interventions that have originated in LMICs.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
BMJ Innovations
BMJ Innovations Medicine-Medicine (all)
CiteScore
4.20
自引率
0.00%
发文量
63
期刊介绍: Healthcare is undergoing a revolution and novel medical technologies are being developed to treat patients in better and faster ways. Mobile revolution has put a handheld computer in pockets of billions and we are ushering in an era of mHealth. In developed and developing world alike healthcare costs are a concern and frugal innovations are being promoted for bringing down the costs of healthcare. BMJ Innovations aims to promote innovative research which creates new, cost-effective medical devices, technologies, processes and systems that improve patient care, with particular focus on the needs of patients, physicians, and the health care industry as a whole and act as a platform to catalyse and seed more innovations. Submissions to BMJ Innovations will be considered from all clinical areas of medicine along with business and process innovations that make healthcare accessible and affordable. Submissions from groups of investigators engaged in international collaborations are especially encouraged. The broad areas of innovations that this journal aims to chronicle include but are not limited to: Medical devices, mHealth and wearable health technologies, Assistive technologies, Diagnostics, Health IT, systems and process innovation.
期刊最新文献
Biomechanical analysis of delivering chest compressions in virtual reality simulation: preliminary insights into fidelity and validity of virtual reality as a means of delivering life support training iCount: a human-factors engineered solution to vaginal swab retention – an early-stage innovation report Spreading and scaling innovation and improvement: understanding why the differences matter Role of twinnings in scaling up innovative solutions across Europe Wings of Healing: regulatory landscape, case studies and the Indian prologue of drones in healthcare
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1